Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?

Novavax (NVAX) shares soared 19.2% in the last trading session to close at $14.68. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.8% loss over the past four weeks. Last month, the FDA granted emergency use authorization to an updated version of the company's proteinbased COVID-19 vaccine for individuals aged 12 years and older. The vaccine has been designed to target the JN.1 strain. Following this nod, Novavax's updated vacci ...